Hybrid Program for Substance Use Prevention in Upper Elementary Students
School-based Hybrid Intervention to Prevent Vaping and Prescription Drug Misuse
Vaping+5
+ Drug Misuse
+ Behavior
Prevention Study
Summary
Study start date: January 1, 2026
Actual date on which the first participant was enrolled.This study aims to address the growing issues of vaping and prescription drug misuse among upper elementary school students in the U.S. It focuses on developing a preventive program from a positive youth development perspective, which has been missing in current prevention efforts. The study is important because it targets young children, among whom these risky behaviors are increasingly starting earlier. By incorporating both online learning and traditional classroom sessions, the program teaches students about the dangers of vaping, the correct use of prescription drugs, and builds social skills, aiming to prevent substance use before it begins. Participants in this study will engage with a hybrid program that includes digital learning and classroom activities designed to be interactive and engaging. The effectiveness of the program will be evaluated through a national trial, comparing students who participate in the program with those who receive standard health education. The study measures changes in behaviors, attitudes, and knowledge about vaping and prescription drug use over time. By integrating e-learning modules, the program not only reduces the demands on classroom time but also enhances reach and engagement, potentially setting a new standard for substance use prevention in schools across the country.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.3000 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Prevention Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 7 to 11 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Inclusion Criteria: Students will be eligible for participation if they attend a school enrolled in the trial and they are between ages 7-11. Exclusion Criteria: All students will be eligible to participate in intervention implmentation, but survey responses will be excluded from the formal analysis with documentation of significant cognitive impairment as determined by school officials.
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalStudy Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location